Calendario›BIIB›BG9418

BG9418

Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)

Ensayo de BIOGEN INC. en Prenatal Exposure Delayed Effects · Multiple Sclerosis · Pregnancy (del registro, en inglés).

Más ensayos de: Esclerosis múltiple.

Fase

no aplica

Estado

Completado

Participantes

329

previstos

Centros

1

Fin del objetivo primario

sep 2011

fecha real

Qué significa cada fase y cada estado.

Estudio observacional. Comenzó en feb 2004.

Qué mide

Record and analyze birth defects and spontaneous fetal losses (Prospectively, MS women exposed to Avonex within 1 week of conception or during the first trimester of pregnancy) (del registro, en inglés)

Cómo lo describe el promotor

En el documentoEn inglés, del registroThe primary objectives of the study were to prospectively record and analyze birth defects and spontaneous fetal losses in women with multiple sclerosis (MS) exposed to Avonex within approximately 1 week of conception or during the first trimester of pregnancy, where the outcome of the pregnancy was unknown prospectively and to prospectively record and analyze pregnancy outcomes in an exploratory fashion of women with MS who stopped therapy, but who may have been exposed to Avonex with approximately 1 week of conception or during the first trimester of pregnancy.

Más ensayos de BIIB

Todos los de BIIB, en su ficha.

Ficha completa en ClinicalTrials.gov (NCT00168714), actualizada en jun 2014.